Recursion Pharmaceuticals is a biotechnology company that combines artificial intelligence (AI) and experimental biology to discover and develop new treatments for various diseases. They leverage their proprietary platform to rapidly identify potential drug candidates and accelerate the drug discovery process. Recursion Pharmaceuticals focuses on diseases with high unmet medical needs, including rare genetic disorders, oncology, and inflammation. Their goal is to bring innovative therapies to patients and improve outcomes through the power of AI-driven drug discovery.

The stock of Recursion Pharmaceuticals, ticker symbol RXRX, has recently broken out of a long-term base. 

A breakout occurs when the stock price moves above a significant resistance level, indicating a potential shift in market sentiment and a breakout from a period of consolidation. Breaking out of a long-term base is often seen as a bullish signal, suggesting that the stock may have the potential for further upward movement.